The current project would utilize MLC-2v expression as a genetic marker of the process of ventricular specification during the earliest stages of murine cardiogenesis (i.e., primitive heart tube). The project would integrate unique reagents (antibodies, cDNA probes, expression vectors, cDNA libraries) with in vitro systems (gel shift/mutagenesis/DEPC interference), embryonic stem cell models of ventricular specification, and transgenic model systems. To exact cause-effect relationships between individual factors and ventricular specification, a variety of approaches would be employed to manipulate the expression of specific candidate genes, including microinjection of neutralizing antibodies in cultured ventricular muscle cells, single and double allelic knockouts via homologous recombination in embryonic stem cells, and the generation of transgenic mice which are homozygous for these inactivated alleles of interest by using these ES cells for blastocyst transgenesis. Accordingly, the Specific Aims would be four-fold: 1) To examine the role of a positively acting cis regulatory element (HF-1b) and its corresponding trans-acting factor in the ventricular specification of MLC-2 gene expression during murine cardiogenesis. 2) To examine the role of an adjacent cis regulatory element (HF-1a) and its corresponding trans-acting factor(s) in the process of ventricular specification of MLC-2 expression. 3) To identify the role of a negative regulatory element (HF-3) and its corresponding trans-acting factor(s) in the ventricular specification of MLC-2 expression. 4) To examine the potential interaction of these positive and negative regulatory pathways in the process of ventricular specification.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL051549-04
Application #
2029036
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1994-01-01
Project End
1998-12-31
Budget Start
1997-02-20
Budget End
1997-12-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Gruber, P J; Kubalak, S W; Chien, K R (1998) Downregulation of atrial markers during cardiac chamber morphogenesis is irreversible in murine embryos. Development 125:4427-38
Sheng, Z; Knowlton, K; Chen, J et al. (1997) Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 272:5783-91
Ruiz-Lozano, P; Doevendans, P; Brown, A et al. (1997) Developmental expression of the murine spliceosome-associated protein mSAP49. Dev Dyn 208:482-90
Becker, K D; Gottshall, K R; Hickey, R et al. (1997) Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assemb J Cell Biol 137:131-40
Christensen, G; Wang, Y; Chien, K R (1997) Physiological assessment of complex cardiac phenotypes in genetically engineered mice. Am J Physiol 272:H2513-24
Tanaka, N; Mao, L; DeLano, F A et al. (1997) Left ventricular volumes and function in the embryonic mouse heart. Am J Physiol 273:H1368-76
Wollert, K C; Chien, K R (1997) Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J Mol Med 75:492-501
Wollert, K C; Taga, T; Saito, M et al. (1996) Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 271:9535-45
Ross, R S; Navankasattusas, S; Harvey, R P et al. (1996) An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and established an anterior-posterior gradient of expression. Development 122:1799-809
Sheng, Z; Pennica, D; Wood, W I et al. (1996) Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 122:419-28

Showing the most recent 10 out of 14 publications